{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:12:31Z","timestamp":1692850351927},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"8","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s15006-017-9045-3","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T05:12:47Z","timestamp":1493701967000},"page":"60-68","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Die Pr\u00e4vention und Therapie Aktinischer Keratosen","Prevention and therapy of actinic keratoses"],"prefix":"10.1007","volume":"159","author":[{"given":"Harald P. M.","family":"Gollnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"9045_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","volume":"161","author":"C Ulrich","year":"2009","unstructured":"Ulrich C, J\u00fcrgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, Eberle J, Terhorst D, Sterry W, Stockfleth E. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol. 2009;161:78\u201384","journal-title":"Br J Dermatol"},{"key":"9045_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1024\/0040-5930.56.4.225","volume":"56","author":"J Grundmann","year":"1999","unstructured":"Grundmann J, Gollnick H. Pr\u00e4ventivma\u00dfnahmen gegen UV-Lichtsch\u00e4den: \u00e4u\u00dferer und innerer Lichtschutz. Therapeutische Umschau.1999;56:225\u201332","journal-title":"Therapeutische Umschau"},{"key":"9045_CR3","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1056\/NEJM199310143291602","volume":"329","author":"SC Thompson","year":"1993","unstructured":"Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329:1147\u201351","journal-title":"N Engl J Med"},{"key":"9045_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0140-6736(98)12168-2","volume":"354","author":"A Green","year":"1999","unstructured":"Green A, Williams G, Neale R et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet. 1999;354:723\u20139","journal-title":"Lancet"},{"key":"9045_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000064534","volume":"15","author":"AK Greul","year":"2002","unstructured":"Greul AK, Grundmann JU, Heinrich F, Pfitzner I, Bernhardt J, Ambach A Biesalski HK, Gollnick H. Photoprotection of UV-Irradiated Human Skin: An Antioxidative Combination of Vitamins E and C, Carotenoids, Selenium and Proanthocyanidins. Skin Pharmacol Appl Skin Physiol. 2002;15:307\u201315","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"9045_CR6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/archderm.139.4.451","volume":"139","author":"S Darlington","year":"2003","unstructured":"Darlington S, Williams G, Neale R et al. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol. 2003;139:451\u20135","journal-title":"Arch Dermatol"},{"key":"9045_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/10715769609088019","volume":"24","author":"H Biesalski","year":"1996","unstructured":"Biesalski H, Hemmes Ch, Hopfenm\u00fcller W, Schmid Ch, Gollnick H. Effects of controlled exposure of sunlight on plasma and skin levels of \u00df-carotene. Free Rad Res. 1996;24:215\u201324","journal-title":"Free Rad Res"},{"key":"9045_CR8","first-page":"200","volume":"6","author":"H Gollnick","year":"1996","unstructured":"Gollnick H, Hopfenm\u00fcller W, Hemmes Ch, Chun S, Schmid Ch, Sundermeier K, Biesalski H. Systemic beta carotene plus topical UV-sunscreen are an optimal protection against harmful effects of natural UV-sunlight: results of the Berlin-Eilath study. Eur J Dermatol. 1996;6:200\u20135","journal-title":"Eur J Dermatol"},{"key":"9045_CR9","doi-asserted-by":"publisher","unstructured":"Nichols B, Amber HA, Shareef Sh, Badiavas DV, Kirsner RS, Ioannidis T. Association of HPV vaccine with development of keratinocyte carcinomas. JAMA Dermatol. 2017; doi: 10.1001\/jamadermatol.2016.5703. [Epub ahead of print]","DOI":"10.1001\/jamadermatol.2016.5703"},{"key":"9045_CR10","first-page":"1953","volume":"119","author":"MC Hughes","year":"2006","unstructured":"Hughes MC, van der Pols JC, Marks GC, Green AC. Food intake and risk of squamous cell carcinoma of the skin in a community: The Nambour skin cancer cohort study. IJC. 2006;119:1953\u201360","journal-title":"IJC"},{"key":"9045_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/bjd.12420","volume":"169","author":"RN Werner","year":"2013","unstructured":"Werner RN, Sammain A, Erdmann R et al. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169:502\u201318","journal-title":"Br J Dermatol"},{"key":"9045_CR12","doi-asserted-by":"publisher","unstructured":"Dirschka T, Pellacani G. Micali G, Malvehy J, Stratigos AJ, Casari A, Schmitz L, Gupta G. Athens AK Study Group. A Proposed Scoring System for Assessing the Severity of Actinic Keratosis on the Head: Actinic Keratosis Area and Severity Index (AKASI). J Eur Acad Dermatol Venereol. 2017; doi: 10.1111\/jdv.14267. [Epub ahead of print]","DOI":"10.1111\/jdv.14267"},{"key":"9045_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1684\/ejd.2014.2265","volume":"24","author":"E Stockfleth","year":"2014","unstructured":"Stockfleth E et al. Reduction in lesions from Lmax: a new concept for assessing efficacy of field-directed therapy for actinic keratosis. Eur J Dermatol. 2014;24:23\u20137","journal-title":"Eur J Dermatol"},{"key":"9045_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00006534-198707000-00007","volume":"80","author":"AJ Emmett","year":"1987","unstructured":"Emmett AJ, Broadbent GD. Shave excision of superficial solar skin lesions. Plast Reconstr Surg. 1987;80:47\u201354","journal-title":"Plast Reconstr Surg"},{"key":"9045_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0190-9622(86)70083-2","volume":"14","author":"GB Winton","year":"1986","unstructured":"Winton GB, Salasche SJ. Dermabrasion of the scalp as a treatment for actinic damage. J Am Acad Dermatol. 1986;14:661\u20138","journal-title":"J Am Acad Dermatol"},{"key":"9045_CR16","first-page":"17","volume":"22","author":"WP Coleman 3rd","year":"1996","unstructured":"Coleman WP 3rd, Yarborough JM, Mandy SH. Dermabrasion for prophylaxis and treatment of actinic keratoses. Dermatol Surg. 1996;22:17\u201321","journal-title":"Dermatol Surg"},{"key":"9045_CR17","first-page":"976","volume":"142","author":"BM Hantash","year":"2006","unstructured":"Hantash BM, Stewart DB, Cooper ZA, Rehmus WE, Koch RJ, Swetter SM. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol. 2006;142:976\u201382","journal-title":"Arch Dermatol"},{"key":"9045_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1067\/mjd.2002.119649","volume":"47","author":"RM Szeimies","year":"2002","unstructured":"Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C, Sidoroff A, Hempel M, Ulrich J, Proebstle T, Meffert H, Mulder M, Salomon D, Dittmar HC, Bauer JW, Kernland K, Braathen L. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002;47:258\u2013262","journal-title":"J Am Acad Dermatol"},{"key":"9045_CR19","first-page":"669","volume":"7","author":"JM Berlin","year":"2008","unstructured":"Berlin JM, Rigel DS. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery. J Drugs Dermatol. 2008 Jul;7:669\u201373","journal-title":"J Drugs Dermatol"},{"key":"9045_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0190-9622(82)70143-4","volume":"7","author":"RR Lubritz","year":"1982","unstructured":"Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol. 1982;7:631\u20132","journal-title":"J Am Acad Dermatol"},{"key":"9045_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1524-4725.1996.tb00361.x","volume":"22","author":"J Kalivas","year":"1996","unstructured":"Kalivas J. Cryosurgery of actinic keratoses: the patient\u2019s perspective. Dermatol Surg. 1996;22:486","journal-title":"Dermatol Surg"},{"key":"9045_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1365-4632.2004.02056.x","volume":"43","author":"KE Thai","year":"2004","unstructured":"Thai KE, Fer gin P, Freeman M et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol. 2004;43:687\u201392","journal-title":"Int J Dermatol"},{"key":"9045_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00105-004-0865-6","volume":"56","author":"CC Zouboulis","year":"2005","unstructured":"Zouboulis CC, R\u00f6hrs H. Cryosurgical treatment of actinic keratoses and evidence-based review. Hautarzt. 2005;56:353\u20138","journal-title":"Hautarzt"},{"key":"9045_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1046\/j.1524-4725.2000.99197.x","volume":"26","author":"SE Chiarello","year":"2000","unstructured":"Chiarello SE. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison. Dermatol Surg. 2000;26:728\u201332","journal-title":"Dermatol Surg"},{"key":"9045_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/lsm.20012","volume":"34","author":"S Iyer","year":"2004","unstructured":"Iyer S, Friedli A, Bowes L, Kricorian G, Fitzpatrick RE. Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer. Lasers Surg Med. 2004;34:114\u20139","journal-title":"Lasers Surg Med"},{"key":"9045_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/146288301753377852","volume":"3","author":"U Wollina","year":"2001","unstructured":"Wollina U, Konrad H, Karamfilov T. Treatment of common warts and actinic keratoses by Er:YAG laser. J Cutan Laser Ther. 2001;3:63\u20136","journal-title":"J Cutan Laser Ther"},{"key":"9045_CR27","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.joms.2006.10.023","volume":"65","author":"SD Sherry","year":"2007","unstructured":"Sherry SD, Miles BA, Finn RA. Long-term efficacy of carbon dioxide laser resurfacing for facial actinic keratosis. J Oral Maxillofac Surg. 2007;65:1135\u20139","journal-title":"J Oral Maxillofac Surg"},{"key":"9045_CR28","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1046\/j.1524-4725.1999.99035.x","volume":"25","author":"JE Fulton","year":"1999","unstructured":"Fulton JE, Rahimi AD, Helton P, Dahlberg K, Kelly AG. Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers. Dermatol Surg. 1999;25:729\u201332","journal-title":"Dermatol Surg"},{"key":"9045_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/09546630310012118","volume":"14","author":"M Freeman","year":"2003","unstructured":"Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, Thai KE, Murrell D, Weightman W, Anderson C, Reid C, Watson A, Foley P. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treatm. 2003;14:99\u2013106","journal-title":"J Dermatolog Treatm"},{"key":"9045_CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00015550510042868","volume":"86","author":"HC Wulf","year":"2006","unstructured":"Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol. 2006;86:25\u20138","journal-title":"Acta Derm Venereol"},{"key":"9045_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","volume":"156","author":"CM Perrett","year":"2007","unstructured":"Perrett CM, McGregor JM, Warwick J et al. Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol. 2007;156:320\u20138","journal-title":"Br J Dermatol"},{"key":"9045_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1600-0536.2007.01243.x","volume":"57","author":"T Hohwy","year":"2007","unstructured":"Hohwy T, Andersen KE, S\u00f8lvsten H, Sommerlund M. Allergic contact dermatitis to methyl aminolevulinate after photodynamic therapy in 9 patients. Contact Dermatitis. 2007;57:321\u20133","journal-title":"Contact Dermatitis"},{"key":"9045_CR33","first-page":"2342","volume":"29","author":"N Kerrouche","year":"2015","unstructured":"Kerrouche N, Szeimies R-M. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. JEADV. 2015;29:2342\u20138","journal-title":"JEADV"},{"key":"9045_CR34","first-page":"673","volume":"26","author":"SR Wiegell","year":"2011","unstructured":"Wiegell SR, Wulf HC, Szeimies RM, Basset-Seguin N et al. Daylight photodynamic therapy for actinic keratosis: an international consensus. JEADV. 2011:26:673\u201379","journal-title":"JEADV"},{"key":"9045_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2133.2012.11200.x","volume":"168","author":"SR Wiegell","year":"2013","unstructured":"Wiegell SR, Fabricius S, Heydenreich J, Enk CD, Rosso S, B\u00e4umler W, Baldursson BT, Wulf HC. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations. Br J Dermatol. 2013;168:186\u201391","journal-title":"Br J Dermatol"},{"key":"9045_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1124\/jpet.302.1.18","volume":"302","author":"R Yamazaki","year":"2002","unstructured":"Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S. Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells. J Pharmacol Exp Ther. 2002;302:18\u201325","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl.3","key":"9045_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.07856.x","volume":"156","author":"LF Fecker","year":"2007","unstructured":"Fecker LF, Stockfleth E, Nindl I, Ulrich C, Forschner T, Eberle J. The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs). Br J Dermatol. 2007;156(Suppl. 3):25\u201333","journal-title":"Br J Dermatol"},{"key":"9045_CR38","first-page":"910","volume":"96","author":"S Quist","year":"2016","unstructured":"Quist S, Wiswedel I, Quist J, Gollnick H. Kinetic profile of inflammation markers in human skin in vivo following UV exposure to UVB indicates synchronic release of cytokines and prostanoids. ActaDermVenereol. 2016;96:910\u20136","journal-title":"ActaDermVenereol"},{"key":"9045_CR39","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1080\/10715760701531430","volume":"41","author":"I Wiswedel","year":"2007","unstructured":"Wiswedel I, Keilhoff G, D\u00f6rner L, Navarro A, B\u00f6ckelmann R, Bonnekoh B, Gardemann A, Gollnikc H. UVB irradiation-induced impairment of keratinocytes and adaptive responses to oxidative stress. Free Radical Res. 2007;41:1017\u201327","journal-title":"Free Radical Res"},{"key":"9045_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1046\/j.1365-4362.2001.01324.x","volume":"40","author":"JR Wolf","year":"2001","unstructured":"Wolf JR, Taylor JR, Tschen E. Topical 3% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol, 2001;40:709\u201313","journal-title":"Int J Dermatol"},{"key":"9045_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1046\/j.1440-0960.2002.00635.x","volume":"44","author":"K Gebauer","year":"2003","unstructured":"Gebauer K, Brown P, Varigos G. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australas J Dermatol. 2003;44:40\u20133","journal-title":"Australas J Dermatol"},{"key":"9045_CR42","first-page":"629","volume":"2","author":"S Smith","year":"2003","unstructured":"Smith S, Piacquadio D, Morhenn V, Atkin D, Fitzpatrick R. Short incubation PDT versus 5-FU in treating actinic keratoses. J Drugs Dermatol.2003;2:629\u201335","journal-title":"J Drugs Dermatol"},{"key":"9045_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00403-005-0601-9","volume":"297","author":"D Pirard","year":"2005","unstructured":"Pirard, D, Vereecken, P, Mélot, C, Heenen, M. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies. Arch Dermatol Res. 2005;297:185","journal-title":"Arch Dermatol Res"},{"key":"9045_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1365-2133.2002.04561.x","volume":"146","author":"JK Rivers","year":"2002","unstructured":"Rivers JK, Arlette J, Shear N et al. Topical treatment of actinic keratoses with 3,0% diclofenac in 2,5% hyaluronan gel. Br J Dermatol. 2002;146:94\u2013100","journal-title":"Br J Dermatol"},{"key":"9045_CR45","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1468-3083.2009.03399.x","volume":"24","author":"T Dirschka","year":"2010","unstructured":"Dirschka T, Bierhoff E, Pflugfelder A, Garbe C. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses. J Eur Acad Dermatol Venereol. 2010;24:258\u201363","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"9045_CR46","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1610-0379.2012.08019.x","volume":"10Suppl","author":"E Stockfleth","year":"2012","unstructured":"Stockfleth E, Terhorst D, Hauschild A, Zouboulis CC, Schlaeger M, Oster-Schmidt C, Diepgen TL, Garbe C, Gollnick H, Korting HC, Merk H, Sterry W, Kerl H, Berking C. Aktinische Keratosen. JDDG. 2012;10(Suppl 7):S1\u2013S23","journal-title":"JDDG"},{"key":"9045_CR47","first-page":"156","volume":"5","author":"SR Smith","year":"2006","unstructured":"Smith, SR, Morhenn, VB, Piacquadio, DJ. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatol. 2006;5:156","journal-title":"J Drugs Dermatol"},{"key":"9045_CR48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.0105-1873.2006.0645f.x","volume":"54","author":"L Kowalzick","year":"2006","unstructured":"Kowalzick L, Ziegler H. Photoallergic contact dermatitis from topical diclofenac in Solaraze gel. Contact Dermatitis. 2006;54:348\u20139","journal-title":"Contact Dermatitis"},{"key":"9045_CR49","first-page":"979.e1","volume":"70","author":"G Micali","year":"2014","unstructured":"Micali G, Lacarrubba F, Nasca MR, Ferraro S, Schwartz RA.Topical pharmacotherapy for skin cancer: part II. Clinical applications. JAmAcadDermatol. 2014;70:979.e1\u2013e12","journal-title":"JAmAcadDermatol"},{"key":"9045_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10227-005-0148-6","volume":"9","author":"AK Gupta","year":"2005","unstructured":"Gupta AK, Davey V, Mcphail H. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies. J Cutan Med Surg. 2005;9:209\u201314","journal-title":"J Cutan Med Surg"},{"key":"9045_CR51","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1365-2133.2006.07164.x","volume":"154","author":"E Epstein","year":"2006","unstructured":"Epstein, E. Twice daily vs. four times daily 5-fluorouracil therapy for actinic keratoses: a split face study. Br J Dermatol. 2006;154:794\u20135","journal-title":"Br J Dermatol"},{"key":"9045_CR52","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1365-2133.2005.06858.x","volume":"153","author":"CS Jury","year":"2005","unstructured":"Jury CS, Ramraka-Jones VS, Gudi V, Herd RM. A randomized trial of topical 5% 5-fluorouracil in the treatment of actinic keratoses comparing daily with weekly treatment. Br J Dermatol. 2005;153:808\u201310","journal-title":"Br J Dermatol"},{"key":"9045_CR53","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/bjd.14498","volume":"175","author":"U Reinhold","year":"2016","unstructured":"Reinhold U, Dirschka T, Ostendorf R, Aschoff R, Berking C, Philipp-Dormston WG, Hahn S, Lau K, J\u00e4ger A, Schmitz B, L\u00fcbbert H, Szeimies RM. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz\u00ae) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(\u00ae) lamp. Br J Dermatol. 2016;175:696\u2013705","journal-title":"Br J Dermatol"},{"key":"9045_CR54","first-page":"2006","volume":"5","author":"MR Johnson","year":"1999","unstructured":"Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB: Life threatening toxicity in a dihydropyrimidin-dehydrogenase-deficiency patient after treatment with topical 5-fluorouracil. Clin Cancer Res. 1999;5:2006\u201311","journal-title":"Clin Cancer Res"},{"key":"9045_CR55","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1365-2133.2011.10387.x","volume":"165","author":"E Stockfleth","year":"2011","unstructured":"Stockfleth E, Kerl H, Zwingers T, Willers C. Low-dos 5 fluorouracil in combination with salicylic acid as a new lesion directed option to treat topically actinic keratosis histological and clinical results. Br J Dermatol. 2011;165:1101\u20138","journal-title":"Br J Dermatol"},{"key":"9045_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1600-0536.2007.01079.x","volume":"57","author":"BU Meijer","year":"2007","unstructured":"Meijer BU, de Waard-van der Spek FB. Allergic contact dermatitis because of topical use of 5-fluorouracil (Efudix cream). Contact Dermatitis. 2007;57:58\u201360","journal-title":"Contact Dermatitis"},{"key":"9045_CR57","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/ni758","volume":"3","author":"H Hemmi","year":"2002","unstructured":"Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002;3:196\u2013200","journal-title":"Nat Immunol"},{"key":"9045_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","volume":"21","author":"RL Miller","year":"1999","unstructured":"Miller RL, Gerster JF, Owens ML, Slade HB, Tomai MA. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacol. 1999;21:1\u201314","journal-title":"Int J Immunopharmacol"},{"key":"9045_CR59","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jnci\/djg016","volume":"95","author":"M Sch\u00f6n","year":"2003","unstructured":"Sch\u00f6n M, Bong AB, Drewniok C, Herz J, Geilen CC, Reifenberger J, Benninghoff B, Slade HB, Gollnick H, Sch\u00f6n MP (2003) Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst. 95:1138\u201349","journal-title":"J Natl Cancer Inst"},{"key":"9045_CR60","first-page":"985","volume":"141","author":"VL Brown","year":"2005","unstructured":"Brown VL, Atkins CL, Ghali L, Cerio R, Harwood CA, Proby CM. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Arch Dermatol. 2005;141:985\u201393","journal-title":"Arch Dermatol"},{"key":"9045_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2133.2007.07942.x","volume":"157","author":"A Alomar","year":"2007","unstructured":"Alomar A, Bichel J, McRae S. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of Imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. Br J Dermatol. 2007;157:133\u201341","journal-title":"Br J Dermatol"},{"key":"9045_CR62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jaad.2006.05.030","volume":"55","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Angelousi AG, Peppas G. Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2006;55:537\u20138","journal-title":"J Am Acad Dermatol"},{"key":"9045_CR63","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1517\/14656566.2011.549128","volume":"12","author":"SR Quist","year":"2011","unstructured":"Quist SR, Gollnick HP. Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratosis. Expert Opinion on Pharmacotherapy. 2011;12:451\u201361","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"9045_CR64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1684\/ejd.2014.2265","volume":"24","author":"E Stockfleth","year":"2014","unstructured":"Stockfleth E et al. Reduction in lesions from Lmax: a new concept for assessing efficacy of field-directed therapy for actinic keratosis. Results with imiquimod 3.75%. Eur J Dermatol. 2014;24:23\u20137","journal-title":"Eur J Dermatol"},{"key":"9045_CR65","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1111\/jdv.13063","volume":"29","author":"LP Samorano","year":"2015","unstructured":"Samorano LP et al. Evaluation of the tolerability and safety of a 0.015% ingenolmebutate gel compared to 5% 5-fluorouracil cream for the treatment of facial keratosis: a prospective randomized trial. J Eur Acad Dermatol Venereol. 2015;29:1822\u20137","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9045_CR66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/bjd.14222","volume":"174","author":"C Garbe","year":"2016","unstructured":"Garbe C, Basset-Seguin N, Poulin Y,Larsson T, \u00d8sterdal ML, Venkata R, Lear JT. Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0,015% gel: a randomized, controlled 12-month study. Br J Derm. 2016;174:505\u201313","journal-title":"Br J Derm"},{"key":"9045_CR67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/CCID.S28905","volume":"5","author":"B Berman","year":"2012","unstructured":"Berman, B. New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel. Clin Cosmet Investig Dermatol. 2012;5:111\u201322","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"9045_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000255058","volume":"124","author":"G St\u00fcttgen","year":"1962","unstructured":"St\u00fcttgen, G. Zur Lokalbehandlung von Keratosen mit Vitamin-A-S\u00e4ure. Dermatologica 1962;124:65","journal-title":"Dermatologica"},{"key":"9045_CR69","first-page":"66","volume-title":"Retinoids in Cutaneous Malignancy","author":"AL Kligman","year":"1991","unstructured":"Kligman AL, Thorne EG. Topical therapy of actinic keratoses with tretinoin. In: Retinoids in Cutaneous Malignancy (Marks R, ed.), Oxford: Blackwell Scientific Publications, 1991; S.66\u201373"},{"key":"9045_CR70","first-page":"185","volume-title":"Tumoren der Haut","author":"H Gollnick","year":"2010","unstructured":"Gollnick H, G\u00f6ppner A. Retinoide. \u2014 In: Tumoren der Haut \/ hrsg. von R.-M. Szeimies Stuttgart [u.a.]: Thieme 2010, S. 185\u201393"},{"key":"9045_CR71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-3-540-79341-0_22","volume-title":"Non-surgical treatment of keratinocyte skin cancer","author":"A G\u00f6ppner","year":"2010","unstructured":"G\u00f6ppner A, Gollnick H. Skin Cancer: Antioxidants and Diet. In: Jemec, Gregor (Eds.). \u2014 Non-surgical treatment of keratinocyte skin cancer. \u2014Springer Heidelberg, Berlin, New York. 2010, S.177\u2013185"},{"key":"9045_CR72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/carcin\/bgn248","volume":"30","author":"E Yiasemides","year":"2009","unstructured":"Yiasemides E, Sivapirabu G, Halliday GM, Park J, Damian DL. Oral nicotinamide protects against ultraviolet radiation induced immunosuppression in humans. Carcinogenesis. 2009;30:101\u20135","journal-title":"Carcinogenesis"},{"key":"9045_CR73","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/jid.2011.459","volume":"132","author":"D Surjana","year":"2012","unstructured":"Surjana D, Halliday GM, Martin AJ, Moloney FJ, Damian DL. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol. 2012;132:1497\u2013500.","journal-title":"J Invest Dermatol"},{"key":"9045_CR74","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","volume":"373","author":"A Chen","year":"2015","unstructured":"Chen A, Chen C, Martin AJ, Choy B, Fernandez-Penas P, Dalziell RA, McKenzie CA, Richard A, Scolyer RA, Dhillon HM, Vardy JL, Kricker A, George G, Chinniah N, Halliday GM, Diona L, Damian DL. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer. Chemoprevention. N Engl J Med. 2015;373:1618\u201326","journal-title":"N Engl J Med"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-017-9045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T10:54:26Z","timestamp":1692788066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-017-9045-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["9045"],"URL":"https:\/\/doi.org\/10.1007\/s15006-017-9045-3","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}